Celldex Therapeutics, Inc. (CLDX) Announces Upcoming Presentation at the Credit Suisse 2013 Antibody Day
5/6/2013 9:33:01 AM
Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!
NEEDHAM, Mass., May 6, 2013 (GLOBE NEWSWIRE) -- Celldex Therapeutics, Inc. (Nasdaq:CLDX) announced today that Tibor Keler, Ph.D., Senior Vice President and Chief Scientific Officer, will present an overview of the Company's antibody technology and pipeline at the Credit Suisse Antibody Day on Friday, May 10, 2013 at 11:00 am ET in New York.
Help employers find you! Check out all the jobs and post your resume.
comments powered by